Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Plasma-based biomarkers present a promising approach in the research and clinical practice of Alzheimer's disease as they are inexpensive, accessible and minimally invasive. In particular, prognostic biomarkers of cognitive decline may aid in planning and management of clinical care. Although r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivisäkk, Pia, Magdamo, Colin, Trombetta, Bianca A, Noori, Ayush, Kuo, Yi kai E, Chibnik, Lori B, Carlyle, Becky C, Serrano-Pozo, Alberto, Scherzer, Clemens R, Hyman, Bradley T, Das, Sudeshna, Arnold, Steven E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257670/
https://www.ncbi.nlm.nih.gov/pubmed/35800899
http://dx.doi.org/10.1093/braincomms/fcac155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257670/
https://www.ncbi.nlm.nih.gov/pubmed/35800899
http://dx.doi.org/10.1093/braincomms/fcac155

Ejemplares similares